Navigation Links
Iowa State chemists track how drug changes, blocks flu virus
Date:2/1/2008

AMES, Iowa An anti-virus drug attacks influenza A by changing the motion and structure of a proton channel necessary for the virus to infect healthy cells, according to a recently published research paper by two Iowa State University chemists.

Mei Hong, Iowa States John D. Corbett Professor in Chemistry, and Sarah Cady, a graduate student in chemistry, are studying the effects of the antiviral drug amantadine on influenza A. Thats the type of flu bug that most commonly makes people sick and the one that has caused the most serious flu epidemics.

Their findings appear in the Feb. 5 edition of the Proceedings of the National Academy of Sciences.

Hong said the findings are particularly important because mutations of the type A virus are resistant to amantadine treatment.

In the last few years, amantadine resistance has skyrocketed among influenza A viruses in Asia and North America, making it imperative to develop alternative antiviral drugs, Hong and Cady wrote in their paper.

To develop those drugs, Hong said researchers first need to understand exactly how amantadine stops the flu virus.

First, some background about how a flu virus infects a healthy cell: A virus begins the process by attaching itself to a healthy cell. The healthy cell surrounds the flu virus and takes it inside the cell through a process called endocytosis. Once in the cell, the virus uses a protein called M2 to open a channel to the healthy cell. Protons from the healthy cell flow through the channel into the virus and raise its acidity. That triggers the release of the virus genetic material into the healthy cell. The virus hijacks the healthy cells resources and uses them to reproduce and spread the virus.

If the M2 proton channel is blocked, the process doesnt work and a virus cant infect a cell and spread.

Hong and Cady studied the proton channel with the help of solid-state nuclear magnetic resonance spe
'/>"/>

Contact: Mei Hong
mhong@iastate.edu
515-294-3521
Iowa State University
Source:Eurekalert  

Page: 1 2

Related medicine news :

1. Sharing Miracles Television Program to Feature North Carolina State Womens Basketball Coach Kay Yow
2. Obesity Action Coalition Calls on the State of Mississippi House of Representatives to Withdraw House Bill 282 Discriminating Against Those Affected by Obesity
3. Experimental Vaccine Halts Prostate Cancer in Mice
4. MedWaves, Inc. Announces Receipt of United States Food and Drug Administration 510k Clearance to Market Its Patented Microwave Coagulation/Ablation System
5. CAHI Releases Updated Health Insurance Mandates in the States
6. Los Angeles Daily Journal Names Richardson & Patel Verdict Top in the State of California for 2007
7. SAFC Pharma Expands Its Pharmorphix Solid State Chemistry Services
8. Researchers investigate links between prostate, cadmium, zinc
9. Pennsylvania Education Secretary Lauds Action on Measure to Create Statewide School Health Benefits System
10. Urinary dysfunction troubles men who undergo prostate removal
11. Capital BlueCross CEO Says Meaningful Statewide Competition Must Be Key Criteria in Pennsylvanias Review of Proposed Highmark-IBC Merger

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Iowa State chemists track how drug changes, blocks flu virus
Iowa State chemists track how drug changes, blocks flu virus
(Date:11/29/2009)... treatment equals a $41,000 pay raise, researchers...ws) -- Psychological therapy may be much more effe...or winning a lottery prize, suggests an English st...f people who provided information about their ment...ness from a $1,329 course of therapy was so signif...
(Date:11/29/2009)...he YogaForce A-Line Athletic Mat is great. It,s a...., author and physician best known for establishin...ne. Go to www.yogaforce.com and order the new M... , San Francisco, CA (PRWE...ays, the YogaForce newly patented, revolutionary A...
(Date:11/28/2009)...RNewswire/ -- Welcome to syngo® .plaza(... routine from Siemens Healthcare. As the first...CS) from Siemens where 2D, 3D, and 4D reading co...sed to change the way multimodality images are rea... the 95th Scientific Assembly and Annual Meeting o...
(Date:11/28/2009)... to consider change after 30-minute psychosocial i.... 27 (HealthDay News) -- A program that gets persi...op their dangerous behavior may lead to significan.... , The new study included 184 men and women wi... who were randomly assigned to one of two interven...
(Date:11/28/2009)...pirits, recognize signs of depression , ,...eniors, the holiday season can trigger melancholy ... health issues or worry about money problems, acco...help overcome the seasonal blues, the AGS Foundati...: , Get out and socialize or invite family and f...
Breaking Medicine News(10 mins):Health News:Psychotherapy Can Boost Happiness More Than Money: Study 2Health News:The YogaForce A-Line Mat Provides The Perfect Solution For Fitness Needs 2Health News:The YogaForce A-Line Mat Provides The Perfect Solution For Fitness Needs 3Health News:Siemens Healthcare Unveils syngo.plaza at RSNA 2009 2Health News:Siemens Healthcare Unveils syngo.plaza at RSNA 2009 3Health News:Drunk Drivers May Respond to Brief Motivational Interview 2Health News:Seniors May Need Help Overcoming Holiday Blues 2
...ass., Jan. 15 No one who survives life-threatenin...rson who entered. In her new memoir, "It Gets Bett...orhouse.com ), Maria Machado Munroe draws together... prose she creates an inspirational recounting for...
...n. 15 Kim Alexis is a supermodel, athlete, mother... the Look," where women compete to be the world,s ...Multimedia News Release, go to: http://www.prnews...of energy for no apparent reason, she grew concern...
...ina, Jan. 15 /PRNewswire-Asia-FirstCall/ -- China ..."the Company") (Nasdaq: CSKI ), a,leading fully ...he-counter drugs in the People,s Republic of China...ucts in China since they address common everyday a...
..., Jan. 15 It,s no wonder that millions of America...an Podiatric Medical Association (APMA) estimates ... 75,000 miles on their feet. For many, the pain i...he most common foot problems are ,hammertoes:, a b...
...Jan. 15 Today marked the launch of the National B...ww.nabita.org ). , , NaBITA,s mission: The Nati...ITA) is committed to providing education, developm...vention and intervention. , , NaBITA is a state-...
...IS, Jan. 15 Eli Lilly and Company,(NYSE: LLY ) ...h the United,States Attorney for the Eastern Distr...mer Litigation of the Department of Justice regard...,Zyprexa(R) (olanzapine). , Lilly has been coo...
Other Medicine News:Health News:Cancer as a Crucible: The Story of a Teenage Immigrant Who Survived Cancer and Built a New Life for Herself 2Health News:Cancer as a Crucible: The Story of a Teenage Immigrant Who Survived Cancer and Built a New Life for Herself 3Health News:Video: Supermodel Kim Alexis Joins Forces with the American Association of Clinical Endocrinologists in a National PSA to Raise Awareness About Thyroid Problems 2Health News:China Sky One Medical, Inc. Provides Business Update 2Health News:China Sky One Medical, Inc. Provides Business Update 3Health News:New Smart Toe Implant Lets Foot Surgery Patients Go 'Wireless' 2Health News:New Smart Toe Implant Lets Foot Surgery Patients Go 'Wireless' 3Health News:New Smart Toe Implant Lets Foot Surgery Patients Go 'Wireless' 4Health News:Preventing the Next Virginia Tech -- The National Behavioral Intervention Team Association Launched Today 2Health News:Lilly Resolves Investigations of Past Zyprexa Marketing and Promotional Practices 2Health News:Lilly Resolves Investigations of Past Zyprexa Marketing and Promotional Practices 3Health News:Lilly Resolves Investigations of Past Zyprexa Marketing and Promotional Practices 4Health News:Lilly Resolves Investigations of Past Zyprexa Marketing and Promotional Practices 5Health News:Lilly Resolves Investigations of Past Zyprexa Marketing and Promotional Practices 6Health News:Lilly Resolves Investigations of Past Zyprexa Marketing and Promotional Practices 7
(Date:11/27/2009)...INGTON, Minn, Nov. 27 ACUO TECHNOL...e management software, data migration tools and se...tes Patent and Trademark Office has approved a pat... within a Computer Network." Acuo Technologies is ... intellectual property. In general, the granted pa...
(Date:11/26/2009)...JOHANNESBURG, South Africa, Nov. 26 /PRNewswire/ -...ny of the Year Award in the Generic Pharmaceutical...Limited. ,, (Logo: http://www.newscom.com/cgi-...f the Year Award, the following criteria were used...ey competitors: growth strategy and implementation...
(Date:11/25/2009)...WESTON, Fla., Nov. 25 ...SFX) ("the Company") is pleased to announce that t...n management office in Shanghai, China. ,, ASR ...ng an essential gateway for the development and pr...roducts for children and adults to be distributed ...
Breaking Medicine Technology:Acuo Technologies Announces Patent for Asset Communication Format Within a Computer Network 2Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 2Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 3Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 4American Scientific Resources Inc. Opens Shanghai Location 2Sucrets 28R 29 ICE and Twentieth Century Fox Home Entertainment Challenge Kids to Keep the Environment Healthy this Cold Season 5699 1Sucrets 28R 29 ICE and Twentieth Century Fox Home Entertainment Challenge Kids to Keep the Environment Healthy this Cold Season 5699 2Sucrets 28R 29 ICE and Twentieth Century Fox Home Entertainment Challenge Kids to Keep the Environment Healthy this Cold Season 5699 3New Data Show CIMZIA 28R 29 28certolizumab pegol 29 Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients 5696 1New Data Show CIMZIA 28R 29 28certolizumab pegol 29 Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients 5696 2New Data Show CIMZIA 28R 29 28certolizumab pegol 29 Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients 5696 3New Data Show CIMZIA 28R 29 28certolizumab pegol 29 Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients 5696 4New Data Show CIMZIA 28R 29 28certolizumab pegol 29 Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients 5696 5New Data Show CIMZIA 28R 29 28certolizumab pegol 29 Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients 5696 6New Data Show CIMZIA 28R 29 28certolizumab pegol 29 Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients 5696 7New Data Show CIMZIA 28R 29 28certolizumab pegol 29 Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients 5696 8New Data Show CIMZIA 28R 29 28certolizumab pegol 29 Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients 5696 9New Data Show CIMZIA 28R 29 28certolizumab pegol 29 Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients 5696 10Sagent Pharmaceuticals to Present at Two Upcoming Financial Conferences 5693 1Sagent Pharmaceuticals to Present at Two Upcoming Financial Conferences 5693 2
...r 11- and 12-year-olds from,meningitis, whooping c...ATLANTA, Aug 28 The Centers for Disease,Control a...tion and,Respiratory Diseases today announced that... the parents of pre-teens are now available to bro...ts, part of CDC,s Pre-Teen,Vaccine campaign, urge ...
...: ICLL) today,announced that its collaborator Merc...ial of V710, an investigational vaccine for the pr...ctions. This randomized double blind,placebo contr...genicity of,the vaccine candidate in patients with...ial start follows the initiation of a separate Pha...
Other Medicine Technology:Intercell Announces Initiation of Further Phase II Clinical Trial of V710 an Investigational Vaccine to Prevent S. aureus Infection 2Intercell Announces Initiation of Further Phase II Clinical Trial of V710 an Investigational Vaccine to Prevent S. aureus Infection 3
Silicone Sleeve (270 Style)
Meridional Implant (103 Style)
Double Tantalum Clip
Ryan Silicone Strip
Medicine Products: